Factors influencing time to diagnosis of childhood cancer in Ibadan, Nigeria

African Health Sciences

Volumn 9, Issue 4, 2009, Pages 247-253

  James, B O ^a,b   Ajayi, S O ^b   Ogun, O A ^b   Oladokun, R E ^a  

^a UNIVERSITY OF IBADAN   (Nigeria)

^b UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LEUKEMIA; ADOLESCENT; ARTICLE; CANCER DIAGNOSIS; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; DELAYED DIAGNOSIS; DEMOGRAPHY; DEVELOPED COUNTRY; DISEASE DURATION; EARLY DIAGNOSIS; EDUCATIONAL STATUS; FEMALE; HEALTH CARE; HEALTH CARE SYSTEM; HEALTH SURVEY; HODGKIN DISEASE; HUMAN; INFANT; INFORMATION; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; NEPHROBLASTOMA; NIGERIA; PARENT; PATIENT REFERRAL; PRESCHOOL CHILD; SCHOOL CHILD;

ADOLESCENT; CHILD; CHILD HEALTH SERVICES; CHILD, PRESCHOOL; DELAYED DIAGNOSIS; FEMALE; HEALTH SERVICES ACCESSIBILITY; HOSPITALS, UNIVERSITY; HUMANS; INFANT; MALE; NEOPLASM STAGING; NEOPLASMS; NIGERIA; REFERRAL AND CONSULTATION; RISK FACTORS; SEER PROGRAM; SOCIOECONOMIC FACTORS; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 77949504606     PISSN: 16806905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Gatta G, Capocaccia R, Coleman MP, Reiss LAG, Berrino F. Childhood cancer survival in Europe and the United States. Cancer 2002:95:1767-1772.
2. Reaman GH. Pediatric oncology: current views and outcomes. Pediatr Clin N Am 2002; 49:1305-1318.
3. Coebergh JW, Capocaccia R, Gatta G, Magnanin C, Stiller C A. Childhood cancer survival in Europe 1978-1992: the EUROCARE study. Eur J Cancer 2001; 37:671-672.
4. Bonilla M, Moreno N, Marina N, et al. Acute lymphoblastic leukemia in a developing country: Preliminary results of a nonrandomized clinical trial in El Salvador. J Pediatr Hematol Oncol 2000; 22:495-501.
5. Howard SC, Pedrosa M, Lins M, et al. Establishment of a pediatric oncology program and outcomes of childhood acute lymphoblastic leukemia in a resource-poor area. JAMA 2004; 291:2471-2475.
6. Aikhionbare H A, Yakubu A M, Afolayan A E. Neuroblastoma, an under-diagnosed tumour: a seven year experience in Zaria. Ann Trop Paediatr 1988;8:149-152.
7. Familusi J B, Aderele W I, Williams O H. Features of neuroblastoma in African children. East Afr Med J 1979; 55:182-90.
8. Dang-Tan T, Franco E L. Diagnosis Delays in Childhood Cancer: Review. Cancer 2007; 110:703-13.
9. Klein-Geltink JE, Pogany LM, Barr RD, Greenberg ML, Mery LS. Waiting times for cancer care in Canadian children: impact of distance, clinical, and demographic factors. Pediatr Blood Cancer 2005; 44:318-327.
10. Haimi M, Peretz Nahum M, Ben Arush MW. Delay in diagnosis of children with cancer: a retrospective study of 315 children. Pediatr Hematol Oncol 2004; 21:37-48.
11. Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds). SEER Summary Staging Manual-2000: Codes and Coding Instructions, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda MD, 2001.
12. Brown BJ, Bamgboye EA, Sodeinde O. Causes of death in childhood cancer at the department of paediatrics, University College Hospital, Ibadan, Nigeria. Afr J Med Med Sci 2008; 37: 7-13.
13. Fasola FA, Shokunbi WA and Falade AG. Factors determining outcome of management of Patients with Burkitt.s Lymphoma at the University College Hospital Ibadan, Nigeria- An Eleven Year Review. Nig Postgrad Med J 2002; 9; 108-112.
14. Pollock BH, Krischer JP, Vietti TJ. Interval between symptom onset and diagnosis of pediatric solid tumors. J Pediatr 1991; 119:725-32.
15. Fajardo-Gutiérrez A, Sandoval-Mex A M, Mejýá- AranguréJM, Rendón-Macýás ME, Martýń ez-Garcýá Mdel C. Clinical and Social Factors That Affect the Time to Diagnosis of Mexican Children with Cancer. Med Pediatr Oncol 2002; 39:25-31.
16. Miettinen M, Franssila KO, Saxen E: Hodgkin.s disease, lymphocyte predominance nodular: Increased risk of subsequent non-Hodgkin's lymphoma. Cancer 1983; 51:2293-2300.
17. Wirix M, Parys-Vanginderdeuren R, Casteels I, Uyttebrouck A. Delayed diagnosis of Retinoblastoma. Bull Soc Belge Ophtalmol 278, 37-41, 2000.
18. Goddard AG, Kingston JE, Hungerford JL. Delay in diagnosis of retinoblastoma: risk factors and treatment outcome. Br J Ophthalmol 1999; 83:1320-1323.
19. Saha V, Love S, Eden T, Micallef- Eynaud P,MacKinalay G. Determinants of symptom interval in childhood cancer. Arch Dis Child 1993; 68:771-774.
20. Ojesina AI, Akang EEU, Ojemakinde KO. Decline in the frequency of Burkitt's lymphoma relative to other childhood malignancies in Ibadan. Ann Trop Paediatr 2002; 22:159-63.
21. Wallach M, Balmer A, Munier F, Houghton S, Pampallona S, von der Weid N, Beck-Popovic M; Swiss Pediatric Oncology Group; Swiss Childhood Cancer Registry. Shorter Time to Diagnosis and Improved Stage at Presentation in Swiss Patients With Retinoblastoma Treated From 1963 to 2004. Pediatrics 2006; 118:e1493-8.
22. Halperin EC, Friedman HS. Is there a correlation between duration of presenting symptoms and stage of medulloblastoma at the time of diagnosis? Cancer 1996; 78:874-880.
23. National Health Insurance Scheme Decree no. 35 of 1999 Laws of the Federation of Nigeria. www. nigeria-law.org/ National%20Health%20Insurance%20Scheme%20Decree.htm